** Shares of Clarity Pharmaceuticals CU6.AX down 15% to A$3.025, top losers on the S&P/ASX 200 .AXJO benchmark index
** Stock falls as much as 26% to A$2.644 earlier in the day, their lowest level since April 30, 2024
** Radiopharmaceutical co said on Friday HY loss attributable widened to A$23 mln ($14.30 mln) from A$17 mln a year earlier
** Five mln shares change hands, 3.4 times the 30-day average of 1.5 mln
** Stock down 27.6% YTD, including current session's moves
($1 = 1.6080 Australian dollars)
(Reporting by Manasi Dasa in Bengaluru)
((Manasi.DasaSundeep@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。